People
Appointment to strengthen Zelluna’s financial and operational capabilities
Keith Martin to retire as CEO, continue as Non-Executive Director
Chief Medical and Development Officer Debra Barker has decided to leave Polyphor at year end for personal reasons and will support on a part time basis afterwards.
Tan will lead the positioning of Cerecin’s pipeline of highly innovative neurotherapeutics
Genetic testing has become an important medical standard for families with known histories of hereditary disease. Individuals who choose to go through the mental and emotional process of taking a genetic test and absorbing the potentially life-changing conclusions may be disturbed to find out that results of such tests are not always consistent.
Abingworth today announced that Jackie Grant, PhD, MBA, will join Abingworth as a Principal based in the company’s Boston office. Jackie has more than 10 years of scientific, research and business development experience.
Anatara Lifesciences to announce the formation of its Product Development Advisory Board.
Biopharma companies shore up leadership roles with new hires and appointments, at Axcella Health, Twist Bioscience, and more.
Scott Gottlieb, commissioner of the Food and Drug Administration (FDA) is notoriously outspoken. Let’s take a look at some of Gottlieb’s more recent statements.
The U.S. Food and Drug Administration (FDA) is eying the spring of 2019 to finalize its biopharmaceutical classification system-based biowaivers guidelines. On Thursday, the regulatory agency released the draft guidance for public consultation.
PRESS RELEASES